What's new

[CYPRUS MAIL] Daily News Briefing...

Nov-17-23-960x683.jpg

In todays episode, health authorities in the United Kingdom have approved a drug which aims to cure beta thalassaemia and sickle cell disease.

The drug is called Casgevy and utilises a gene-editing tool as Crispr to manipulate the DNA of beta thalassaemia and sickle cell disease sufferers.

Meanwhile, Parliament passed a new law on Thursday which sets out the rights and responsibilities of both employees who work remotely and their employers.

Elsewhere, the forestry department in a written report has blamed the electricity authority (EAC) for the near catastrophic fires in Paphos forest, as well as that in Palaichori, this past summer.

All this and more in the Cyprus Beat briefing brought to you by the Cyprus Mail.


Contents of this article including associated images are belongs Cyprus Mail
Views & opinions expressed are those of the author and/or Cyprus Mail

Source
 
Back
Top